The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia

Chronic Myelogenous Leukemia: Pregnancy in the Era of Stopping Tyrosine Kinase Inhibitor Therapy

(2018) Ellin Berman et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

(2017) A Hochhaus et al.   LEUKEMIA

Management of pregnant chronic myeloid leukemia patients

(2016) Elisabetta Abruzzese et al.   Expert Review of Hematology

The impact of dasatinib on pregnancy outcomes

(2015) Jorge E. Cortes et al.   AMERICAN JOURNAL OF HEMATOLOGY

Epidemiology of chronic myeloid leukaemia: an update

(2015) Martin Höglund et al.   ANNALS OF HEMATOLOGY

Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial

(2015) Jun Imagawa et al.   Lancet Haematology

How I determine if and when to recommend stopping tyrosine kinase inhibitor treatment for chronic myeloid leukaemia

(2014) David M. Ross et al.   BRITISH JOURNAL OF HAEMATOLOGY

TYROSINE KINASE INHIBITORS AND PREGNANCY

(2014) Elisabetta Abruzzese et al.   Mediterranean Journal of Hematology and Infectious Diseases

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

(2013) M. Baccarani et al.   BLOOD

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study

(2013) D. M. Ross et al.   BLOOD

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

(2010) François-Xavier Mahon et al.   LANCET ONCOLOGY

Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study

(2009) Monika Conchon et al.   Journal of Hematology & Oncology

The effects of imatinib on pregnancy outcome

(2008) S. M. Pye et al.   BLOOD

Persistence of molecular remission throughout pregnancy in CML after imatinib

(2008) Federica Sorà et al.   LEUKEMIA RESEARCH